CHMG trades 29.5% above Wall Street's consensus target of $50.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CHMG achieves its forward estimates and maintains a stable P/E multiple of 9.9x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Chemung Financial Corporation (CHMG) has a Wall Street consensus price target of $50.00, based on estimates from 7 covering analysts. With the stock currently trading at $70.97, this represents a potential downside of -29.5%. The company has a market capitalization of $341M.
Analyst price targets range from a low of $50.00 to a high of $50.00, representing a 0% spread in expectations. The median target of $50.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CHMG trades at a trailing P/E of 22.7x and forward P/E of 9.9x. Analysts expect EPS to grow +127.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $63.63, with bear and bull scenarios of $40.09 and $83.84 respectively. Model confidence stands at 46/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CZWICitizens Community Bancorp, Inc. | $205M | $21.34 | — | — | Buy | 11.7x | 2 |
FUNCFirst United Corporation | $277M | $42.58 | $25.00 | -41.3% | Buy | 9.8x | 1 |
PBHCPathfinder Bancorp, Inc. | $104M | $16.87 | — | — | — | — | — |
CFFIC&F Financial Corporation | $255M | $78.36 | — | — | — | 7.6x | — |
AROWArrow Financial Corporation | $641M | $38.80 | $43.00 | +10.8% | Hold | 10.3x | 1 |
NBTBNBT Bancorp Inc. | $2.4B | $46.68 | $46.00 | -1.5% | Hold | 11.2x | 10 |
STBAS&T Bancorp, Inc. | $1.7B | $46.84 | $37.67 | -19.6% | Hold | 12.6x | 12 |
FXNCFirst National Corporation | $265M | $29.36 | $21.00 | -28.5% | Buy | 12.5x | 1 |
TRSTTrustCo Bank Corp NY | $925M | $52.24 | — | — | Hold | 18.2x | 3 |
FISFidelity National Information Services, Inc. | $19.7B | $38.21 | $62.88 | +64.6% | Buy | 6.1x | 37 |
Quick answers to the most common questions about buying CHMG stock.
CHMG's consensus price target is $50, -29.5% below the current price of $70.97. The 7 analysts tracking CHMG see downside risk at present valuations.
CHMG has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $50 implies -29.5% downside from current levels.
With a forward P/E of 9.9259x, CHMG trades at a relatively low valuation. The consensus target of $50 implies -29.5% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $50 for CHMG, while the most conservative target is $50. The consensus of $50 represents the median expectation. Our quantitative valuation model projects a bull case target of $84 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHMG is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHMG stock forecast based on 7 Wall Street analysts shows a consensus price target of $50, with estimates ranging from $50 (bear case) to $50 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $64, with bear/bull scenarios of $40/$84.
Our quantitative valuation model calculates CHMG's fair value at $64 (base case), with a bear case of $40 and bull case of $84. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.
CHMG trades at a forward P/E ratio of 9.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CHMG, with 0 Sell ratings and a price target of $50 (-29.5% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHMG analyst price targets range from $50 to $50, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $50 consensus represents the middle ground. Our model's $40-$84 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.